Heart failure trial blueprint: doctors and patients team up to design smarter study
NCT ID NCT07281040
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is not testing a new drug. Instead, it brings together doctors, nurses, pharmacists, and patients who have recently been hospitalized for heart failure. They will discuss and vote on which additional treatments to test in a future trial, what doses to use, and how to measure success. The goal is to design a larger, more effective study that truly reflects what matters to patients and clinicians.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this preparatory work will help design a large, well-informed clinical trial that could identify better treatments for people hospitalized with heart failure.
- What could go wrong
- This is a small, early planning study with only 10 participants. It does not test any treatment itself, so its impact depends entirely on the future trial it helps design.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
See inclusion / exclusions
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Recent hospitalisation with heart failure (\<6 months) or carer for a person with a recent hospitalisation with heart failure. 2. Able to participate in online group discussions in English Exclusion Criteria: 1\. Unable to participate in online group discussions in English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cardiology
RECRUITINGHull, Yorkshire, HU16 5JQ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaler boost heart pumping in COPD patients?
- Can zapping the heart beat drugs for AF in heart failure?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?